Betty, I didn't read the Forbes article, but was not impressed by the earnings report. Their sales were up slightly, but they had very large increases in expenses for selling and administration, R&D, and plant and equipment.I hope the R&D gets some new products on the market quick. I have owned the stock for awhile, and am disappointed in this years performance. Don't know what to think about management.The 4 million shares they gave for a marketing arrangement had a dilution impact on the earnings per share. Hopefully it will pay off.I might be a buy at this price.